X0306 4 2022-12-01 0 0001797768 Kinnate Biopharma Inc. KNTE 0001771329 Meltz Mark A 103 MONTGOMERY STREET, SUITE 150 THE PRESIDIO OF SAN FRANCISCO SAN FRANCISCO CA 94129 0 1 0 0 COO General Counsel Secretary Common Stock 2022-12-01 4 F 0 541 7.75 D 27924 D Includes 23,438 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. A portion of the RSUs vest each quarter, subject to the Reporting Person's continued service as of each vesting date. Mark A. Meltz 2022-12-02